Fuse Vectors has raised $5.2 million of funding as it moves closer to commercialising its innovative new approach to ...
Ten of 11 children born with a rare form of congenital hearing loss experienced improvements after receiving the company’s ...
Danish biotech replaces 1980s cell-based methods with revolutionary cell-free technology, making gene therapy more accessible. Innovative approach allows for unprecedented quality in hours rather than ...
A gene therapy from Regeneron Pharmaceuticals Inc. improved hearing in nearly all deaf children in a clinical trial, results ...
Regeneron Pharmaceuticals said on Monday its experimental gene therapy showed improved hearing in 10 of 11 children between ...
Researchers from the NIHR Moorfields Biomedical Research Centre and University College London have found that gene therapy improved visual acuity and preserved retinal structure in young children with ...
National Biotechnology Conference, gene therapies, bispecific antibodies and other novel modalities—relative newcomers to ...
1d
GlobalData on MSNSensorion’s Phase I/II gene therapy trial to continue with DMC recommendationSensorion's Audiogene Phase I/II trial of the SENS-501 gene therapy programme has received a favourable recommendation from ...
Hyderabad: Cell and gene therapy solutions provider Miltenyi Biotec on Monday announced the roll-out of what is touted as ...
OTO, is one of several early-stage gene therapies being developed to treat relatively straight-forward causes of genetic ...
An experimental trial of gene therapy has helped four toddlers - born with one of the most severe forms of childhood ...
Four children born with a rare genetic form of severe blindness have all experienced significant improvements in their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results